While the revenue growth remained strong, Syrma’s Q3FY23 EBITDA margins were impacted due to (1) lower exports and 76% decline in healthcare revenues, (2) Steep 3x revenue growth in Consumer business which generates low margins and (3) lower revenues from ODM.